Patrick Bilbo - 15 Feb 2022 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role: Chief Operating Officer
Signature: /s/ William R. Kolb, Attorney-in-Fact
Issuer symbol: ORGO
Transactions as of: 15 Feb 2022
Net transactions value: -$7,290
Form type: 4
Filing time: 17 Feb 2022, 17:55:15 UTC
Previous filing: 12 Nov 2021
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORGO	Class A Common Stock	Award	$0	+52,926	+40%	$0.000000	186,596	15 Feb 2022	Direct	F1
transaction	ORGO	Class A Common Stock	Tax liability	$7,290	-937	-0.5%	$7.78	185,659	16 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORGO	Stock Option (Right to Buy)	Award	$0	+125,522		$0.000000	125,522	15 Feb 2022	Class A Common Stock	125,522	$8.03	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022.
F2	The option becomes exercisable in equal annual installments over four years beginning February 15, 2022.